Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-11-20 00:00:00 ET · period of report 2025-11-18 · accession 0001784606-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-20 | 2025-11-18 | JAZZ | Carr Patricia | SVP, CAO | S - Sale+OE | $182.06 | -5,319 | 7,012 | -43% | -$968.4K |
| D | 2025-11-20 | 2025-11-18 | JAZZ | Carr Patricia | SVP, CAO | M - OptEx | $136.18 | +5,250 | 12.3K | +75% | +$714.9K |
| D | 2025-11-20 | 2025-11-18 | JAZZ | Carr Patricia | SVP, CAO | M - OptEx | $0.00 | -5,250 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-11-18 | S | D | 69 | $181.66 | 7,012 | D | — | — | (F1) The Reporting Person acquired 69 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025. |
| 2 | Common | Ordinary Shares | 2025-11-18 | M | A | 5,250 | $136.18 | 12,262 | D | — | — | |
| 3 | Common | Ordinary Shares | 2025-11-18 | S | D | 5,250 | $182.07 | 7,012 | D | — | — | |
| 4 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-11-18 | M | D | 5,250 | $0.00 | 0 | D | $136.18 · — to 2027-03-01 | 5,250 Ordinary Shares | (F2) These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The option was fully vested as of March 2, 2021. |